Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02459925 · ClinicalTrials.gov registry record · NA
MOMS Hubs- CT Dept of Social Services Block Grant
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 179
- Enrollment target
NCT02459925: Clinical Trial NA study, sponsored by Yale University.
NCT02459925 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 179 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02459925, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
Study Summary
The MOMS Partnership aims to create "MOMS Zones" in New Haven neighborhoods where the hardest to reach families live. These "MOMS Zones" will have two unique features: (1) a MOMS "Hub" to deliver centralized mental health and family economic success services to the hardest to reach families living in New Haven's most impoverished neighborhoods, as measured by actual socio-economic status as well as by access to resources; (2) a neighborhood workforce of Community Mental Health Ambassadors (CMHAs--mothers who themselves live in New Haven). The MOMS Workforce Program and MOMS Mental Health Program will be offered at all three Hubs.
Primary Outcome
Reduced CES-D Score (CES-D score goal \<16)
Interventions
- BEHAVIORAL CBT- Mental Health Program
- BEHAVIORAL MOMS GROW
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2015-04-22 |
| Est. Completion | 2017-05-25 |
| Phase | NA |
Why NCT02459925 stopped before completion
NCT02459925 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which CBT- Mental Health Program is the first listed.
NCT02459925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02459925 about?
NCT02459925 is a clinical study titled "MOMS Hubs- CT Dept of Social Services Block Grant". The MOMS Partnership aims to create "MOMS Zones" in New Haven neighborhoods where the hardest to reach families live. These "MOMS Zones" will have two unique features: (1) a MOMS "Hub" to deliver centralized mental health and family economic success services to the hardest to reach families living i...
What is the current status of trial NCT02459925?
This trial is currently terminated. It is a NA study. The enrollment target is 179 participants. The study started on 2015-04-22. Estimated completion is 2017-05-25.
What interventions are being tested in trial NCT02459925?
The interventions under investigation include: CBT- Mental Health Program (BEHAVIORAL), MOMS GROW (BEHAVIORAL).
Who is sponsoring clinical trial NCT02459925?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02459925's enrollment target sits among peer trials
179 604th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI